BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• Drug Development

  Cornerstone Pharmaceuticals Announces Approval to Conduct Phase I/II Clinical Trial of CPI-613 in Cancer Patients by FDA

  July 24, 2008

   · 

  1 min read
• Business

  Pharmacopeia, Inc. Advances Therapeutic Program With GlaxoSmithKline

  July 24, 2008

   · 

  1 min read
• Business

  Innovative Investment Relationship to Develop Eli Lilly and Company’s Two Lead Alzheimer’s Molecules

  July 24, 2008

   · 

  1 min read
• Business

  Clear Catheter Systems Completes Financing, Opens Cleveland Office

  July 24, 2008

   · 

  2 min read
• Policy

  Alkermes Release: Supplemental New Drug Application for RISPERDAL(R) CONSTA(R) Submitted to the FDA for the Treatment of Bipolar Disorder

  July 24, 2008

   · 

  1 min read
• Business

  Nuvelo, Inc. Reports Second Quarter 2008 Financial Results

  July 24, 2008

   · 

  7 min read
• Business

  Beckman Coulter, Inc. Announces Results for Third Fiscal Quarter

  July 24, 2008

   · 

  6 min read
• Deals

  Spanish Biotech Company Cellerix, S.L. in Deal Talks; IPO Plans Shelved

  July 24, 2008

   · 

  1 min read
• Drug Development

  Alizyme PLC Announces Headline Results from Its European Phase 3 Clinical Trial

  July 24, 2008

   · 

  4 min read
• Business

  GlaxoSmithKline (JOBS) in $25 Million-Plus Deal with Harvard Stem Cell Institute

  July 24, 2008

   · 

  1 min read